newsfilter
← Latest News
FDA Approved Drugs·

Approval of Revtorpyk, Nda #219908 (Type 1 - New Molecular Entity)

Approval Date: 07/14/2026; Drug Name: Revtorpyk, Nda #219908; Active Ingredients: GEDATOLISIB; Company: Celcuity Inc..; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 219908

Company
CELCUITY INC..
Keywords
CELCUITY INC..